Biotherapeutics, Inc.
US UEI DKZNEQL174E3 · SME
38public awards
$16.4Mtotal public funding
2026-07-13latest award
State aid awards (38)
| Date | Amount | Type | Programme | Granted by |
|---|---|---|---|---|
| 2026-07-13 | $356k | Grant | CARDIOVASCULAR DISEASES RESEARCH | Department of Health and Human Services |
| 2026-06-12 | $348k | Grant | CARDIOVASCULAR DISEASES RESEARCH | Department of Health and Human Services |
| 2026-06-01 | $314k | Grant | ALLERGY AND INFECTIOUS DISEASES RESEARCH | Department of Health and Human Services |
| 2026-06-01 | $314k | Grant | ALLERGY AND INFECTIOUS DISEASES RESEARCH | Department of Health and Human Services |
| 2026-05-04 | $360k | Grant | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | Department of Health and Human Services |
| 2026-04-29 | $300k | Grant | ALLERGY AND INFECTIOUS DISEASES RESEARCH | Department of Health and Human Services |
| 2026-02-26 | $296k | Grant | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | Department of Health and Human Services |
| 2026-02-26 | $296k | Grant | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH | Department of Health and Human Services |
| 2026-02-20 | $289k | Grant | CARDIOVASCULAR DISEASES RESEARCH | Department of Health and Human Services |
| 2025-12-17 | $1.1M | Grant | ALLERGY AND INFECTIOUS DISEASES RESEARCH | Department of Health and Human Services |
| 2025-09-20 | $1.9M | Grant | A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis | Department of Health and Human Services |
| 2025-08-13 | $314k | Grant | Next-Gen Oral Therapeutics for Concomitant Clostridioides difficile In | Department of Health and Human Services |
| 2025-08-01 | $314k | Grant | Novel Therapeutic for SLE | Department of Health and Human Services |
| 2025-07-01 | $360k | Grant | Next-Gen Oral Therapeutics for Type 2 Diabetes | Department of Health and Human Services |
| 2025-02-01 | $348k | Grant | The Next Wave of Asthma Therapeutics | Department of Health and Human Services |
| 2024-09-20 | $356k | Grant | Development of Novel Immunoregulatory Therapeutics for Asthma | Department of Health and Human Services |
| 2024-08-20 | $289k | Grant | Development of Novel Therapeutics for Asthma | Department of Health and Human Services |
| 2024-07-01 | $300k | Grant | Comparative Efficacy of Therapeutics for Clostridioides difficile Infe | Department of Health and Human Services |
| 2023-09-20 | $295k | Grant | A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis | Department of Health and Human Services |
| 2023-09-07 | $296k | Grant | Novel first-in-class Therapeutics for Rheumatoid Arthritis | Department of Health and Human Services |
| 2023-09-05 | $296k | Grant | Development of Novel Topical Therapeutics for Psoriasis | Department of Health and Human Services |
| 2023-04-15 | $356k | Grant | Immunoregulatory Therapeutics for Ulcerative Colitis | Department of Health and Human Services |
| 2022-07-01 | $1.1M | Grant | Novel Immunoregulatory Therapeutics for Systemic Lupus Erythematosus | Department of Health and Human Services |
| 2021-08-01 | $362k | Grant | Targeting the Immunometabolic Hub Nlrx1 as a Novel Therapeutic for Ast | Department of Health and Human Services |
| 2021-06-11 | $300k | Grant | The First LANCL2-based therapeutic for influenza | Department of Health and Human Services |
| 2021-01-01 | $300k | Grant | Novel Immunoregulatory Therapeutics for Systemic Lupus Erythematosus | Department of Health and Human Services |
| 2020-09-01 | $295k | Grant | The First Pomegranate Seed Oil-Containing Medical Food for Gut and Imm | Department of Health and Human Services |
| 2020-07-01 | $231k | Grant | Developing Novel NLRX1-Based Immuno-Oncology Therapeutics | Department of Health and Human Services |
| 2020-07-01 | $1.4M | Grant | Effects of Abscisic Acid on Insulin Sensitivity | Department of Health and Human Services |
| 2020-05-12 | $1.1M | Grant | Validation of Immunometabolic NLRX1 Therapeutics for IBD | Department of Health and Human Services |
| 2020-05-01 | $231k | Grant | Novel Immunoregulatory Drugs for Type 1 Diabetes | Department of Health and Human Services |
| 2019-07-01 | $300k | Grant | Development of Antibiotic-Free Clostridium difficile Therapeutics | Department of Health and Human Services |
| 2019-04-01 | $282k | Grant | Effects of Abscisic Acid on Insulin Sensitivity | Department of Health and Human Services |
| 2019-04-01 | $233k | Grant | Immunometabolic NLRX1 Therapeutics for IBD | Department of Health and Human Services |
| 2018-08-21 | $300k | Grant | BT-11: A First-in-class Oral Therapeutic for Inflammatory Bowel Diseas | Department of Health and Human Services |
| 2016-09-01 | $250k | Grant | The First Abscisic Acid-Containing Medical Food for Glycemic Control | Department of Health and Human Services |
| 2013-01-01 | $148k | Grant | PDE4B Inhibitors For Treating Major Depression | Department of Health and Human Services |
| 2013-01-01 | $188k | Grant | Development of Novel LANCL2-based Anti-diabetic Compounds | Department of Health and Human Services |
Want an alert when companies like this one get funded in your sector? Pro waitlist →